Meet the Investors 

Wietse Mulder

2 & 3 April
Investors table

Wietse Mulder | Managing Partner, Myosotis Investments

In 1989 Wietse obtained in Utrecht a master in Chemical Biology. In 1995 he completed his PhD thesis in Molecular Biology at University of Amsterdam. With a few decades of experience in life sciences, he is a seasoned entrepreneur, investor, and board member who is passionate about driving innovation and growth in molecular diagnostics and immunotherapy. Wietse has a proven track record of founding, leading, and selling successful companies, as well as supporting and advising emerging ventures in the field.

He leverages his scientific knowledge and entrepreneurial skills to co-author multiple publications and presentations on topics such as next generation sequencing, hybrid molecules, and HLA loss variants. He is also committed to giving back to the community and raising funds for various charitable causes. He is founder of TxMiller Foundation and Ebiqs Foundation. Wietse is initiator of the Dutch BioBusiness Masterclass supporting start up company and their entrepreneurs


About Myosotis Investments

Myosotis Investments B.V. is a privately held Dutch company established in 2024. We provide financial and business support to various life science enterprises, who preferably are active in the field of molecular diagnostics. Guided by a commitment to a healthier world, Myosotis invests in innovations that drive meaningful, lasting improvements in healthcare and quality of life.

Karpervijver 17, 3703 CJ Zeist, The Netherlands

https://myosotisinvestments.com/


Powered by:
Hyphen Projects   

    Connect     

Join Global Investor Forum

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 

                                    

          Register here
 
© Copyright 2023 by Hyphen Projects